Beta Drugs Limiteds Board approved increasing authorized share capital from INR 10 Crores to INR 10.5 Crores and plans to issue 7,07,651 compulsorily convertible debentures and 100 equity shares on a preferential basis, pending shareholder approval on November 12, 2024.